Abstract
Background
Metabolic syndrome is defined by co-incidence of multiple metabolic disorders such as central obesity, high triglycerides, low HDL, hyperglycemia and high blood pressure, which increases the risk of cardiovascular disease and diabetes. The aim of this study was to estimate the prevalence of metabolic syndrome using Adult Treatment Panel III (ATP-III), International Diabetes Federation (IDF) and Iranian criteria in large-scaled population based cohort study and to determine the concordance between these criteria.
Methods
In the present study all information collected in Tabari cohort study(TCS) were utilized. These information were collected using a structural questionnaire and taking blood samples from all the participants. Blood pressure and anthropometric indices were measured for all participants by trained practitioners. Categorical variables were compared using chi-square test. In addition, the quantitative variables were compared between the two the groups using independent t-test. Kappa coefficient was estimated to show the agreement between the results of the three criteria.
Results
The prevalences of Metabolic syndrome were 41.10%(CI 95%:40.10–42.02), 44.60%(CI 95%:43.61–45.54), and 30.80% (CI 95%:29.89–31.69) based on ATPIII, international IDF and IDF Iranian criteria respectively. The Kappa agreement coefficients between Iranian IDF with ATPIII definition and international IDF were estimated as 61.80% and 71.20% in the total population respectively.
Conclusion
Kappa coefficient showed that the Iranian IDF had a good agreement with International IDF and an intermediate agreement with the ATP-III. Considering more emphasis of international and Iranian IDF on waist circumference (WC), a better agreement between these two criteria is plausible. Regarding the high prevalence of abdominal obesity among Iranian population, applying these criteria to identify high risk persons might be helpful.
Similar content being viewed by others
References
Grundy SM. Metabolic syndrome update. Trends in cardiovascular medicine. 2016;26(4):364–73.
Han TS, Lean ME. Metabolic syndrome. Medicine. 2015;43(2):80–7.
Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014;2014.
Rigo JC, Vieira JL, Dalacorte RR, Reichert CL. Prevalence of metabolic syndrome in an elderly community: comparison between three diagnostic methods. Arq Bras Cardiol. 2009;93(2):85–91.
Hajian-Tilaki K, Heidari B, Firouzjahi A, Bagherzadeh M, Hajian-Tilaki A, Halalkhor S. Prevalence of metabolic syndrome and the association with socio-demographic characteristics and physical activity in urban population of Iranian adults: a population-based study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2014;8(3):170–6.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112(17):2735–52.
Alberti KGM, Zimmet P, Shaw J. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366(9491):1059–62.
Azizi F, Hadaegh F, Khalili D, Esteghamati A, Hosseinpanah F, Delavari A, et al. Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of obesity. Archives of Iranian medicine. 2010;13(5):426–8.
Organization WH. Waist circumference and waist-hip ratio: report of a WHO expert consultation, Geneva, 8-11 December 2008. 2011.
O'neill S, O'driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16(1):1–12.
Ostovar R, Kiani F, Sayehmiri F, Yasemi M, Mohsenzadeh Y, Mohsenzadeh Y. Prevalence of metabolic syndrome in Iran: a meta-analysis. Electron Physician. 2017;9(10):5402–18.
Nolan PB, Carrick-Ranson G, Stinear JW, Reading SA, Dalleck LC. Prevalence of metabolic syndrome and metabolic syndrome components in young adults: a pooled analysis. Prev Med Rep. 2017;7:211–5.
Kheradmand MMM, Saeedi M, Poustchi H, Eghtesad S. Tabari cohort study profile and first results in urban and mountainous regions, Mazandaran. Iran Archives of Iranian medicine. 2019.
Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar A-A, Hekmatdoost A, et al. Prospective epidemiological research studies in Iran (the PERSIAN cohort study): rationale, objectives, and design. Am J Epidemiol. 2017;187(4):647–55.
Eghtesad S, Mohammadi Z, Shayanrad A, Faramarzi E, Joukar F, Hamzeh B, et al. The PERSIAN cohort: providing the evidence needed for healthcare reform. Archives of Iranian medicine. 2017;20(11):691–5.
(NHANES). Anthropometry Procedure Manual. Available from: http:/www.cdc.gov/nchs/data/nhanes/nhanes_07_08/manual_an.pdf.Last.
Amirkalali B, Fakhrzadeh H, Sharifi F, Kelishadi R, Zamani F, Asayesh H, et al. Prevalence of metabolic syndrome and its components in the Iranian adult population: a systematic review and meta-analysis. Iranian Red Crescent Medical Journal. 2015;17(12).
Dalvand S, Niksima SH, Meshkani R, Ghanei Gheshlagh R, Sadegh-Nejadi S, Kooti W, et al. Prevalence of metabolic syndrome among Iranian population: a systematic review and meta-analysis. Iran J Public Health. 2017;46(4):456–67.
Ramli AS, Daher AM, Nor-Ashikin MN, Mat-Nasir N, Ng KK, Miskan M, et al. JIS definition identified more Malaysian adults with metabolic syndrome compared to the NCEP-ATP III and IDF criteria. Biomed Res Int. 2013;2013:760963.
Luksiene DI, Baceviciene M, Tamosiunas A, Reklaitiene R, Radisauskas R. Comparison of four definitions of the metabolic syndrome and odds of ischemic heart disease in the Lithuanian urban population. Int J Public Health. 2012;57(3):543–50.
Houti L, Hamani-Medjaoui I, Lardjam-Hetraf SA, Ouhaibi-Djellouli H, Chougrani S, Goumidi L, et al. Prevalence of metabolic syndrome and its related risk factors in the City of Oran, Algeria: the ISOR study. Ethnicity & disease. 2016;26(1):99–106.
Sharifi F, Mousavinasab S, Saeini M, Dinmohammadi M. Prevalence of metabolic syndrome in an adult urban population of the west of Iran. Exp Diabetes Res. 2009;2009.
Gonzalez-Ortiz M, Martinez-Abundis E, Jacques-Camarena O, Hernandez-Gonzalez SO, Valera-Gonzalez IG, Ramos-Zavala MG. Prevalence of metabolic syndrome in adults with excess of adiposity: comparison of the adult treatment panel III criteria with the international diabetes federation definition. Acta Diabetol. 2006;43(3):84–6.
Misra A, Wasir JS, Vikram NK. Waist circumference criteria for the diagnosis of abdominal obesity are not applicable uniformly to all populations and ethnic groups. Nutrition. 2005;21(9):969–76.
Esteghamati A, Ashraf H, Rashidi A, Meysamie A. Waist circumference cut-off points for the diagnosis of metabolic syndrome in Iranian adults. Diabetes Res Clin Pract. 2008;82(1):104–7.
Bener A, Zirie M, Musallam M, Khader YS, Al-Hamaq AO. Prevalence of metabolic syndrome according to adult treatment panel III and international diabetes federation criteria: a population-based study. Metab Syndr Relat Disord. 2009;7(3):221–9.
Guerrero-Romero F, Rodriguez-Moran M. Concordance between the 2005 international diabetes federation definition for diagnosing metabolic syndrome with the National Cholesterol Education Program Adult Treatment Panel III and the World Health Organization definitions. Diabetes Care. 2005;28(10):2588–9.
Zabetian A, Hadaegh F, Azizi F. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract. 2007;77(2):251–7.
Acknowledgments
Tabari cohort was approved by Mazandaran University of Medical science ethical committee (IR.MAZUMS. REC.1395.2524). Authors thank all the participants, staff, health volunteers and Behvarzes of health centers who were involved in data collection in Sari (number 5) and health houses in Kiasar, Zelemrudbar and Telmadareh for collaborating in data collection. We also appreciate the research deputy of Iranian Ministry of Health and Medical Education, PERSIAN cohort team and Tabari cohort team.
Funding
Tabari cohort study supported by the Iranian Ministry of Health and Medical Education (grant number: 700/534) as well as Mazandaran University of Medical Sciences.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None declared.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bahar, A., Kashi, Z., Kheradmand, M. et al. Prevalence of metabolic syndrome using international diabetes federation, National Cholesterol Education Panel- Adult Treatment Panel III and Iranian criteria: results of Tabari cohort study. J Diabetes Metab Disord 19, 205–211 (2020). https://doi.org/10.1007/s40200-020-00492-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40200-020-00492-6